Posts

Psychedelic Business Spotlight - June 17

Psychedelic Business Spotlight – June 17

, ,
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!

Psychedelic Business Spotlight – April 22

,
This week in psychedelic business news: Mindset Pharma files a new patent; Ehave's MetaHealthU app seeks to cure HPPD; Wellbeing Digital Sciences contemplates a sale.

Psychedelic Business Spotlight – February 4

,
Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news, Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), a psychedelic medicine and wellness...
Sponsored by Mindset Pharma

Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for Psychedelics

The partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader in the industry.
Psychedelic Business Spotlight — January 28

Psychedelic Business Spotlight — January 28

,
This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger.

Interview with James Lanthier, CEO of Mindset Pharma

,
CEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the 4 new psychedelics they are creating. He also discusses some big breaking news!
Psychedelic Business Spotlight — January 7

Psychedelic Business Spotlight — January 7

,
This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life Sciences explores behavioral addictions; Ei.Ventures buys virtual land for psychedelic therapy.
Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds

Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds

It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously.

Psychedelic Business Spotlight – December 31

,
This week in psychedelic business news: Mindset Pharma files another patent for compounds with "perfect microdosing drug profile," and Core One Labs is preparing to capitalize on functional mushroom...
How Mindset Pharma Is Making and Defining 'Next-Generation Psychedelic Drugs'

How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.